UNSPSC 51283708: Cefotiam

This classification denotes a cephalosporin antibiotic with the molecular formula C18H23N9O4S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 91W6Z2N718, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)acetyl)amino)-3-(((1-(2-(dimethylamino)ethyl)-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-trans)- but generally known as cefotiam, which bears US NIH Compound Identifier 43708.

UNSPSC 51283708 Cefotiam, a Commodity code, does not align with the state and local procurement activity recently posted under this designation. The source records show solicitations for naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic pharmaceuticals and over-the-counter products through cooperative purchasing, and direct-to-manufacturer prescription program capabilities—none of which concern cefotiam, a specific third-generation cephalosporin antibiotic. The code assignment appears to be a tagging error in the underlying procurement records. State and local governments do procure pharmaceuticals and medical supplies through multiple channels—individual jurisdictions, state health agencies, and cooperative purchasing alliances—but the opportunities captured here represent broad medical procurement categories rather than narrow-spectrum antibiotics like cefotiam.

The four recent opportunities span Florida county health services, Texas state health agency market research, Tampa municipal emergency services, and multi-state cooperative purchasing covering Minnesota and Oregon. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for naloxone and drug deactivation systems with annual volumes of 1,900 and 800 units respectively. The City of Tampa released an IFB (26P00145, due March 13, 2026) for 169 line items of emergency medical and first aid supplies for its Fire Department Rescue Division, valued at approximately $700,000, with a 5 percent bid discount for certified Small Local Business Enterprises. The Texas HHS Commission posted an RFI (HHS0017013, April 3, 2026) exploring direct-to-manufacturer prescription contracting outside traditional pharmacy benefit managers and wholesalers. MMCAP, the Minnesota Multistate Cooperative Purchasing Alliance, solicited generic pharmaceuticals and OTC products via RFP (S1070000015802, due March 26, 2026) for distribution across state and local facilities in Minnesota and Oregon through authorized wholesalers, with contract effectiveness July 1, 2026. The divergence between the code's nominal scope and actual solicitation content indicates this code sees minimal relevant state and local activity.